EUVIMEDEUVIMED entdecken
Crossref

JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization

Yingying Wei, Zachary Braunstein, Jun Chen, Xinwen Min, Handong Yang, Lihua Duan, Lingli Dong, Jixin Zhong

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Yingying Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Cardiovascular…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) has been considered as a T cell-mediated autoimmune disease. However, the signaling pathways regulating effector T cells in MS have yet to be elucidated. Janus kinase 2 (JAK2) plays a crucial role in hematopoietic/immune cytokine receptor signal transduction. Here, we tested the mechanistic regulation of JAK2 and the therapeutic potential of pharmacological JAK2 inhibition in MS. Both inducible whole-body JAK2 knockout and T cell-specific JAK2 knockout completely prevented the onset of experimental autoimmune encephalomyelitis (EAE), a widely used MS animal model. Mice with JAK2 deficiency in T cells exhibited minimal demyelination and minimal CD45+ leukocyte infiltration in the spinal cord, accompanied by a remarkable reduction of T helper cell type 1 (TH1) and type 17 (TH17) in the draining lymph nodes and spinal cord. In vitro experiments showed that disruption of JAK2 markedly suppressed TH1 differentiation and IFNγ production. The phosphorylation of signal transducer and activator of transcription 5 (STAT5) was reduced in JAK2 deficient T cells, while STAT5 overexpression significantly increased TH1 and IFNγ production in STAT5 transgenic mice. Consistent with these results, JAK1/2 inhibitor baricitinib or selective JAK2 inhibitor fedratinib attenuated the frequencies of TH1 as well as TH17 in the draining lymph nodes and alleviated the EAE disease activity in mice. Our findings suggest that overactive JAK2 signaling in T lymphocytes is the culprit in EAE, which may serve as a potent therapeutic target for autoimmune disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisMiceAnimalsSTAT5 Transcription FactorJanus Kinase 2Spinal CordMice, TransgenicMice, Inbred C57BLTh17 CellsTh1 Cells

Stichwörter der Autor:innen

Experimental Autoimmune EncephalomyelitisJAK2Multiple SclerosisSTAT5T cellT(H)1

Substanzen

STAT5 Transcription FactorJanus Kinase 2

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Cardiovascular Research Institute, Case Western Reserve University, Cleveland, OH 44…
  • Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.
  • Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei 442000, China.
  • Cardiovascular Research Institute, Case Western Reserve University, Cleveland, OH 44106, USA; Department of Rheumatology, Jiangxi Provincial People's Hospital, Nanchang, Jiangxi 330006, China. Electronic address: lh-dua…
  • Department of Rheumatology and Immunology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: tjhdongll@163.com.

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wei, Y., Braunstein, Z., Chen, J., Min, X., Yang, H., Duan, L., Dong, L., & Zhong, J. (2023). JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110382

Vancouver

Wei Y, Braunstein Z, Chen J, Min X, Yang H, Duan L, et al. JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110382

BibTeX
@article{Wei2023,
  author = {Wei, Yingying and Braunstein, Zachary and Chen, Jun and Min, Xinwen and Yang, Handong and Duan, Lihua and Dong, Lingli and Zhong, Jixin},
  title = {JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110382}
}
Kostenlos starten →